The current institutional shareholding score of Editas Medicine Inc is 5.00, ranking 132 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 52.11%, representing a quarter-over-quarter decrease of 22.13%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 4.06% of shares outstanding, with 71.50% increase in holdings.